RVMD
Revolution Medicines Inc Earnings
$40.92
Earnings Summary
Revenue | $0Mn |
Net Profits | $-156.29Mn |
Net Profit Margins | -Inf% |
Revolution Medicines Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its revenue since last 3-months.
Revolution Medicines Inc’s net profit fell -44.13% since last year same period to $-156.29Mn in the Q3 2024. On a quarterly growth basis, Revolution Medicines Inc has generated -17.3% fall in its net profits since last 3-months.
Revolution Medicines Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Revolution Medicines Inc post its latest quarter earningsEPS Estimate Current Year | -0.75 |
Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -0.75.
Key Ratios
Key ratios of the Revolution Medicines Inc post its Q3 2024 earningsEarning Per Share (EPS) | -0.94 |
Revolution Medicines Inc’s earning per share (EPS) jumped 5.05% since last year same period to -0.94 in the Q3 2024. This indicates that the Revolution Medicines Inc has generated 5.05% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | -0.89 | -0.94 | -5.62% |
2024-05-08 | -0.75 | -0.7 | 6.67% |
2024-08-07 | -0.77 | -0.81 | -5.19% |
₹0 US Stocks a/c Opening Fee